Clinical Trial Update: TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN [Phase 3]

View source ↗

Summary

A phase 3 trial comparing TAX + cisplatin + 5-FU versus cisplatin + 5-FU in head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Adrucil (5-fluorouracil) (5-fluorouracil)
• Platinol (Cisplatin) (Cisplatin)
• Taxotere (docetaxel) (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Carcinoma, Squamous Cell | Phase 3 | Status: COMPLETED